Treating Cancer Better.
Intezyne is a clinical stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets. The core technology of Intezyne is a versatile drug delivery platform that generates a sustainable pipeline of patented therapeutics. The Company is currently advancing these assets through various stages of the clinical approval process.